These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16515873)

  • 21. Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein.
    Ezaki J; Takeda-Ezaki M; Koike M; Ohsawa Y; Taka H; Mineki R; Murayama K; Uchiyama Y; Ueno T; Kominami E
    J Neurochem; 2003 Dec; 87(5):1296-308. PubMed ID: 14622109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
    Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
    Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 27. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell death pathways in juvenile Batten disease.
    Persaud-Sawin DA; Boustany RM
    Apoptosis; 2005 Oct; 10(5):973-85. PubMed ID: 16151633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
    Xiong J; Kielian T
    J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.
    Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
    Puranam KL; Guo WX; Qian WH; Nikbakht K; Boustany RM
    Mol Genet Metab; 1999 Apr; 66(4):294-308. PubMed ID: 10191118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle arrest in Batten disease lymphoblast cells.
    Kang S; Kim JB; Heo TH; Kim SJ
    Gene; 2013 May; 519(2):245-50. PubMed ID: 23458879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Batten disease gene product (CLN3p) is a Golgi integral membrane protein.
    Kremmidiotis G; Lensink IL; Bilton RL; Woollatt E; Chataway TK; Sutherland GR; Callen DF
    Hum Mol Genet; 1999 Mar; 8(3):523-31. PubMed ID: 9949212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenol sulfotransferases: candidate genes for Batten disease.
    Dooley TP; Probst P; Obermoeller RD; Siciliano MJ; Doggett NA; Callen DF; Mitchison HM; Mole SE
    Am J Med Genet; 1995 Jun; 57(2):327-32. PubMed ID: 7668357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The function of CLN3P, the Batten disease protein.
    Rakheja D; Narayan SB; Bennett MJ
    Mol Genet Metab; 2008 Mar; 93(3):269-74. PubMed ID: 18688960
    [No Abstract]   [Full Text] [Related]  

  • 37. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
    Vitiello SP; Wolfe DM; Pearce DA
    Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells.
    Wang MJ; Liu S; Liu Y; Zheng D
    Neurosci Res; 2007 Sep; 59(1):40-6. PubMed ID: 17707539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cln3 in human NT2 neuronal precursor cells and neonatal rat brain.
    Pane MA; Puranam KL; Boustany RM
    Pediatr Res; 1999 Oct; 46(4):367-74. PubMed ID: 10509355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Blumenfeld Z
    J Neurochem; 2007 Nov; 103(3):962-71. PubMed ID: 17680997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.